For: | Shan BB, Li Y, Zhao C, An XQ, Zhang QM. Efficacy of EGFR-TKI sequential therapy in patients with EGFR exon 19 insertion-positive non-small-cell lung cancer: A case report. World J Clin Cases 2022; 10(6): 1883-1888 [PMID: 35317151 DOI: 10.12998/wjcc.v10.i6.1883] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i6/1883.htm |
Number | Citing Articles |
1 |
Yingying Jiang, Xiaoxu Fang, Yan Xiang, Tingwen Fang, Jingwen Liu, Kaihua Lu. Afatinib for the Treatment of NSCLC with Uncommon EGFR Mutations: A Narrative Review. Current Oncology 2023; 30(6): 5337 doi: 10.3390/curroncol30060405
|
2 |
William Shaffer, Ikei S. Kobayashi, Daniel Sentana-Lledo, Shriram Sundararaman, Meghan D. Lee, Deepa Rangachari, Paul A. VanderLaan, Susumu S. Kobayashi, Daniel B. Costa. EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors. Lung Cancer 2023; 181: 107250 doi: 10.1016/j.lungcan.2023.107250
|